Related Experiment Video
Updated: Feb 25, 2026
Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells
Published on: October 1, 2010
In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening
Maxime Louet1, Sara Bitam2, Naziha Bakouh2
1INSERM, UMR_S 973, Université Paris Diderot, 39 rue Hélène Brion, 75013, Paris, France.
Insights
Researchers modeled the human ClC-Kb channel, a target for hypertension treatment. They identified six molecules, including diflusinal and loperamide, that block this chloride channel, offering new therapeutic possibilities.
Area of Science:
- Molecular Biology
- Pharmacology
- Biophysics
Background:
- The human ClC-Kb channel is crucial for chloride ion export.
- Dysfunction of ClC-Kb is linked to Bartter syndrome type 3 and hypertension.
- ClC-Kb is a potential therapeutic target for hypertension.
Purpose of the Study:
- To build a structural model of the human ClC-Kb channel.
- To investigate sequence-structure-function relationships and mutation impacts.
- To identify novel inhibitors for the ClC-Kb channel.
Main Methods:
- Comparative modeling to build the ClC-Kb channel structure.
- In silico and in vitro techniques to analyze the chloride ion pathway and mutations.
- Virtual screening and drug repositioning for inhibitor discovery.
Main Results:
- A structural model of the human ClC-Kb channel was successfully constructed.
- Analysis provided insights into amino acids in the chloride pathway and mutation roles.
- Six novel blocking molecules, including diflusinal and loperamide, were identified with low micromolar Kd values.
Conclusions:
- The developed structural model aids in understanding ClC-Kb channel function and mutations.
- Identified molecules serve as a foundation for designing new ClC-Kb inhibitors.
- These findings support ClC-Kb as a viable therapeutic target for hypertension.
Abstract:
The human ClC-Kb channel plays a key role in exporting chloride ions from the cytosol and is known to be involved in Bartter syndrome type 3 when its permeation capacity is decreased. The ClC-Kb channel has been recently proposed as a potential therapeutic target to treat hypertension. In order to gain new insights into the sequence-structure-function relationships of this channel, to investigate possible impacts of amino-acid substitutions, and to design novel inhibitors, we first built a structural model of the human ClC-Kb channel using comparative modeling strategies. We combined in silico and in vitro techniques to analyze amino acids involved in the chloride ion pathway as well as to rationalize the possible role of several clinically observed mutations leading to the Bartter syndrome type 3. Virtual screening and drug repositioning computations were then carried out. We identified six novel molecules, including 2 approved drugs, diflusinal and loperamide, with Kd values in the low micromolar range, that block the human ClC-Kb channel and that could be used as starting point to design novel chemical probes for this potential therapeutic target.
Related Concept Videos
01:18Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:24Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
01:26Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:19Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...